The French network of Regional Pharmacovigilance Centres evaluated in 1997
the prevalence of adverse effects of drugs (AED). In 1998, and again with t
he support of the French Drug Agency, in collaboration with the company CEM
KA for economic evaluations, the incidence of AED-related hospitalizations
in the medical department of French public hospitals was studied. The evalu
ation was performed over 14 consecutive days in 62 hospital departments, wh
ich were selected randomly. The total number of 3137 patients were hospital
ized for a mean duration of 9 days and they were using a mean number of six
different drugs. Taking into account the number of about 4 million patient
s admitted per year in the hospitals represented, it was estimated that the
total number of AED-related hospitalizations amounts to about 130 000 annu
ally (CI95%: 100 916-156 620). Using established cost calculations for hosp
italized days (AP-HP, results of 1996) the mean cost for an AED-related hos
pitalization was estimated to be about FF16 000.